Table 3 Comparison of baseline medication between patients who died and who were alive at 1 year
Medications | Died at 1 year (n = 39) n (%) | Alive at 1 year (n = 357) n (%) | p-value |
|---|---|---|---|
Antiplatelet | 37 (94.9%) | 350 (98.0%) | 0.219 |
Aspirin | 34 (91.9%) | 332 (94.9%) | 0.439 |
Clopidogrel | 13 (35.1%) | 143 (40.9%) | 0.500 |
Ticagrelor | 2 (5.4%) | 7 (2.0%) | 0.209 |
Warfarin | 9 (24.3%) | 58 (16.6%) | 0.236 |
Beta-blocker | 29 (74.4%) | 273 (76.5%) | 0.769 |
Bisoprolol | 1 (3.4%) | 34 (12.5%) | 0.223 |
Metoprolol succinate | 0 (0.0%) | 6 (2.2%) | 1.000 |
Metoprolol tartrate | 5 (17.2%) | 24 (8.8%) | 0.176 |
Carvedilol | 20 (69.0%) | 197 (72.2%) | 0.716 |
Nebivolol | 0 (0.0%) | 0 (0.0%) | – |
Atenolol | 1 (3.4%) | 10 (3.7%) | 1.000 |
Propranolol | 2 (6.9%) | 2 (0.7%) | 0.047 |
Non-guideline-recommended | 8 (27.6%) | 36 (13.2%) | 0.050 |
beta-blocker (metoprolol tartrate or atenolol or propanolol) | |||
ACE inhibitors | 16 (41.0%) | 154 (43.1%) | 0.800 |
ARB | 11 (28.2%) | 99 (27.7%) | 0.950 |
Nitrates | 12 (30.8%) | 116 (32.5%) | 0.827 |
Hydralazine | 3 (7.7%) | 34 (9.5%) | 1.000 |
Trimetazidine | 3 (7.7%) | 26 (7.3%) | 1.000 |
Ivabradine | 3 (7.7%) | 8 (2.2%) | 0.084 |
Diuretics | 30 (76.9%) | 255 (71.4%) | 0.468 |
Digitalis | 7 (17.9%) | 42(11.8%) | 0.302 |
Statins | 36 (94.7%) | 333 (99.7%) | 0.029 |
Insulin | 8 (57.1%) | 47 (41.2%) | 0.256 |
Sulfonylureas | 4 (28.6%) | 57 (50.0%) | 0.130 |
Biguanides | 6 (42.9%) | 52 (45.6%) | 0.845 |
Thiazolidinediones | 0 (0.0%) | 3 (2.6%) | 1.000 |